Vycellix

MediSix Therapeutics

This company develops cellular therapies for patients with T-cell malignancies, autoimmune diseases and solid tumours using its proprietary genetic engineering platform.

Allogene Therapeutics

The company develops off-the-shelf allogeneic CAR T-cell therapies for patients with blood cancers, solid tumours and autoimmune diseases.

LYEL

This company develops engineered cell therapies to treat patients with solid tumours and blood cancers.

T-CURX

This biotech company develops non-viral CAR-T cell therapies to treat patients with leukaemia, lymphoma and solid tumours.

Appia Bio

This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Cellemedy

The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.